Redeye comments on the news of the discontinued partnership between CTEK and General Motors.
Redeye gives a short comment on today’s news that Curasight’s TO2 program yielded DKK5.
Aspo downgraded its full year EBITA guidance to EUR ~30m (previously over EUR 32m).
Redeye resumes coverage of OXE Marine following its major debt restructuring and equity boost.
Tangiamo Touch Technology (”Tangiamo” eller ”bolaget”) meddelade den 6 december 2024 att bolaget har...
- Strong momentum and long runway for growth highlighted - Military modernisation and market share g...
ExpreS2ion Biotechnologies har nått en viktig operativ milstolpe med godkännandet av bolagets fas 1-...
Redeye provides its Q3 2024 update for the Swedish Quality Microcap theme.
Uniquely positioned in an attractive market Positioned for further growth and scaling Key customer r...
CEO highlighted an accelerating market for mission-critical IT infrastructure Main drivers are cyber...
PHI är ett medicintekniskt bolag som utvecklar och marknadsför icke-invasiva time-lapse imaging-inst...
Ework is not just a consultancy broker Demand will gradually pick up, but the pace is uncertain Marg...
XP Chemistries fick en RFI (request for information) från EFSA (European Food Safety Authority) gäll...
Redeye is encouraged by the announcement of a strategic restructuring of Champion Health Plus.
CirChem (”CirChem” eller ”Bolaget”) uppvisade en rekordstark nettoomsättning om 10,2 MSEK (0,7) unde...